CompletedNot Applicable

Suturable DuraGen™ PMCF Study

United States106 participantsStarted 2021-04-28

Plain-language summary

The primary goal of this study is to retrospectively collect data on the safety and efficacy of Suturable DuraGen™.

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Subject is between 18 and 80 years of age
✓. Subject has undergone either a supratentorial, an infratentorial, or a spinal procedure with the use of Suturable DuraGen™ prior to trial initiation
✓. Availability of post-operative assessment results.

Patient Outcome

Timeframe: post-up to 90 days

NCT IDNCT04923867

SponsorIntegra LifeSciences Corporation

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2024-07-31